0

No products in the cart.

0

No products in the cart.

Home Business Amdocs director Amos Genish buys $149,730 in shares
Business

Amdocs director Amos Genish buys $149,730 in shares

Updated 14 minutes Ago1 Mins read0 Views
Share
Amdocs director Amos Genish buys 9,730 in shares
Share


Amdocs director Amos Genish buys $149,730 in shares

Source link

Share
Amylyx avexitide trial meets primary endpoint for hypoglycemia Previous post Amylyx avexitide trial meets primary endpoint for hypoglycemia

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles
Ohio Valley Banc director Michael Isaac buys ,999 in shares
Business

Nylim MacKay portfolio manager sells $46,266 in MMD shares

3 minutes Ago
Amylyx avexitide trial meets primary endpoint for hypoglycemia
Business

Amylyx avexitide trial meets primary endpoint for hypoglycemia

23 minutes Ago
Lilly presents obesity drug trial results at ObesityWeek 2026
Business

Lilly presents obesity drug trial results at ObesityWeek 2026

31 minutes Ago
After midterm sweep, Democrats split over Trump, cost-cutting agenda
Business

After midterm sweep, Democrats split over Trump, cost-cutting agenda

42 minutes Ago

Keep in touch

Subscribe to our newsletter to get our newest articles instantly!

    Copyright 2025. All rights reserved

    © Copyright 2022 Jellywp. All rights reserved powered by Jellywp.com